Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
Burmester G, Stigler J, Rubbert-Roth A, Tanaka Y, Azevedo V, Coombs D, Lagunes I, Lippe R, Wung P, Gensler L. Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials. Rheumatol Ther 2024; 11:737-753.
29.04.2024
Safety Profile of Upadacitinib up to 5 Years in Psoriatic Arthritis, Ankylosing Spondylitis, and Non-radiographic Axial Spondyloarthritis: An Integrated Analysis of Clinical Trials.
29.04.2024
Rheumatol Ther 2024; 11:737-753
Burmester Gerd R, Stigler Jayne, Rubbert-Roth Andrea, Tanaka Yoshiya, Azevedo Valderilio F, Coombs Derek, Lagunes Ivan, Lippe Ralph, Wung Peter, Gensler Lianne S
Weiter
